CLINICAL_TRIALS
trial_result
· 2022-02-16
Clinical Trial Update: Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) [Phase 3]
Summary
Phase 3 trial evaluating efficacy and safety of asenapine using an active control in adults with schizophrenia or schizoaffective disorder; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED